British pharmaceutical company AstraZeneca announced on May 20 its intention to build a 1.5 billion USD facility in Singapore to produce new generation cancer treatment drugs. Illustrative photo (Photo: bssnews.net)Hanoi (VNA) – British pharmaceutical company AstraZeneca announced on May 20 its intention to build a 1.5 billion USD facility in Singapore to produce new generation cancer treatment drugs. In its announcement, AstraZeneca also unveiled that the plant is supported by the Singapore Economic Development Board (EDB). Png Cheong Boon, EDB’s Chairman said that they welcome AstraZeneca's decision to establish a manufacturing presence in Singapore for the first time. It will also be a first for AstraZeneca – an end-to-end manufacturing facility for novel antibody drug conjugates that enables precision therapy for cancer, he continued.

Source: Bangladesh Sangbad Sangstha May 20, 2024 14:59 UTC